FDA Warns Five Companies of Aggressive New Approach to CBD Enforcement
Dykema (Cannabis Law Blog)
DECEMBER 7, 2022
In its Constituent Update, the FDA states broadly that the companies are selling CBD products “that people may confuse for traditional foods or beverages which may result in unintentional consumption or overconsumption of CBD.” [1]. Dykema will continue to monitor and provide updates on FDA’s policy and enforcement positions on these matters.
Let's personalize your content